Should You Buy the 5 Highest-Paying Dividend Stocks in the Dow Jones Before 2026?

The article identifies the Dow’s five highest-yielding names—Verizon (6.66%), Chevron (4.55%), Merck (3.23%), Amgen (3.00%) and Coca‑Cola (2.92%)—and outlines why each merits investor attention: Verizon as a high-income, rate‑sensitive telecom; Chevron as a cash‑generative, fully integrated oil major (≈$187bn revenue over the past four quarters) supporting a sustainable dividend; Merck as a dividend‑steady pharma with a strong pipeline but facing Keytruda patent loss in 2028; Amgen as a dividend grower with key drug drivers and a sub‑50% payout ratio; and Coca‑Cola as a defensive, long‑standing Dividend King. Analysts highlighted Chevron, Merck and Coca‑Cola as the more attractive buys heading into 2026, while noting the SPDR Dow Jones ETF (DIA) offers a lower‑risk, broad exposure alternative (1.46% yield).

Analysis

The article identifies the Dow's five highest-yielding names by headline yield: Verizon at 6.66%, Chevron at 4.55% (with ~ $187 billion in revenue over the past four quarters), Merck at 3.23%, Amgen at 3.00% (payout ratio below 50% and annual dividend increases since 2011), and Coca‑Cola at 2.92% (63 consecutive years of increases). It characterizes Verizon as a rate‑sensitive income play, Chevron as a fully integrated, cash‑generative oil major supporting its dividend, Merck and Amgen as dividend‑paying pharmas with pipelines and upcoming patent risk, and Coca‑Cola as a defensive Dividend King. Analysts cited Chevron, Merck and Coca‑Cola as the more attractive buys heading into 2026, while the SPDR Dow Jones ETF (DIA) is presented as a lower‑risk, diversified alternative with a 1.46% yield. Key risks flagged in the piece include commodity cyclicality for Chevron and Merck's impending Keytruda patent loss in 2028; the article also discloses position/recommendation biases (author holds KO; Motley Fool holds/recommends several tickers). The aggregated signals show a mildly positive tone and modest market impact, supporting selective income bias rather than broad market conviction.

Key Decisions for Investors

• Consider a selective overweight to Chevron for yield and cash‑generation exposure but size positions small enough to manage oil‑price cyclicality or hedge with derivatives
• Add or hold Merck for dividend stability and pipeline optionality while setting explicit monitoring triggers for Keytruda patent developments into 2028
• Maintain or accumulate Coca‑Cola as a defensive, long‑duration dividend core holding for portfolios prioritizing income and capital preservation
• Use Verizon tactically for income if the investor expects Fed rate cuts, but avoid concentrating telecom dividend risk without assessing coverage and business growth prospects
• If preferring lower idiosyncratic risk, allocate to the SPDR Dow Jones ETF (DIA) for Dow exposure at a 1.46% yield rather than individual high‑yield names